Top compounds associated with response to EIF2D


Feature Type Standardized
Nominal ANOVA
mRNA HG-5-113-01 GDSC1000 pan-cancer AAC 0.13 0.006
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.089 0.007
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.11 0.007
mRNA CP724714 GDSC1000 pan-cancer AAC -0.096 0.007
mRNA TW 37 GDSC1000 pan-cancer AAC 0.094 0.007
mRNA niclosamide CTRPv2 pan-cancer AAC 0.1 0.008
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.008
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.009
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.009
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.089 0.009
Download CSV